CY2009A - Benzenedimethanol suitable for micronisation - Google Patents

Benzenedimethanol suitable for micronisation

Info

Publication number
CY2009A
CY2009A CY200998A CY200998A CY2009A CY 2009 A CY2009 A CY 2009A CY 200998 A CY200998 A CY 200998A CY 200998 A CY200998 A CY 200998A CY 2009 A CY2009 A CY 2009A
Authority
CY
Cyprus
Prior art keywords
salt
benzenedimethanol
hydroxy
hydroxynaphthoate
micronisation
Prior art date
Application number
CY200998A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CY2009A publication Critical patent/CY2009A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
CY200998A 1990-11-29 1998-02-20 Benzenedimethanol suitable for micronisation CY2009A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026005A GB9026005D0 (en) 1990-11-29 1990-11-29 Drug material suitable for micronisation
PCT/GB1991/002108 WO1992009557A1 (en) 1990-11-29 1991-11-28 Benzenedimethanol suitable for micronisation

Publications (1)

Publication Number Publication Date
CY2009A true CY2009A (en) 1998-02-20

Family

ID=10686212

Family Applications (1)

Application Number Title Priority Date Filing Date
CY200998A CY2009A (en) 1990-11-29 1998-02-20 Benzenedimethanol suitable for micronisation

Country Status (27)

Country Link
US (1) US5380922A (xx)
EP (2) EP0639176B1 (xx)
JP (1) JP3375626B2 (xx)
KR (1) KR100192196B1 (xx)
AT (1) ATE144244T1 (xx)
AU (1) AU644505B2 (xx)
BG (1) BG61340B1 (xx)
CA (1) CA2099586C (xx)
CY (1) CY2009A (xx)
CZ (1) CZ282996B6 (xx)
DE (1) DE69122780T2 (xx)
DK (1) DK0639176T3 (xx)
ES (1) ES2093812T3 (xx)
FI (2) FI118155B (xx)
GB (1) GB9026005D0 (xx)
GR (1) GR3022088T3 (xx)
HK (1) HK78997A (xx)
HU (1) HU218205B (xx)
IE (1) IE914146A1 (xx)
OA (2) OA09861A (xx)
PL (2) PL167976B1 (xx)
RU (2) RU2116293C1 (xx)
SG (1) SG49741A1 (xx)
SK (1) SK281095B6 (xx)
TW (1) TW309425B (xx)
WO (1) WO1992009557A1 (xx)
ZA (1) ZA919401B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
AU1229892A (en) * 1992-02-11 1993-09-03 Glaxo Group Limited Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
JP2002541183A (ja) 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
AU2001292929A1 (en) 2000-09-26 2002-04-08 Temple University Of The Commonwealth System Of Higher Education Analgesic and glucosamine compositions
EP2127641A1 (en) 2008-05-26 2009-12-02 Inke, S.A. Micronisable form of salmeterol xinafoate
KR101100614B1 (ko) 2010-09-20 2011-12-29 한국수력원자력 주식회사 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en) * 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation

Also Published As

Publication number Publication date
FI932422A (fi) 1993-05-27
FI932422A0 (fi) 1993-05-27
RU2197475C2 (ru) 2003-01-27
GR3022088T3 (en) 1997-03-31
GB9026005D0 (en) 1991-01-16
HK78997A (en) 1997-06-20
SG49741A1 (en) 1998-06-15
PL169722B1 (pl) 1996-08-30
CA2099586C (en) 2002-06-25
BG61340B1 (en) 1997-06-30
ATE144244T1 (de) 1996-11-15
OA10024A (en) 1996-10-14
TW309425B (xx) 1997-07-01
AU9040291A (en) 1992-06-25
BG97767A (bg) 1994-12-02
HU218205B (hu) 2000-06-28
US5380922A (en) 1995-01-10
FI118203B (fi) 2007-08-31
WO1992009557A1 (en) 1992-06-11
DK0639176T3 (da) 1996-12-23
SK54593A3 (en) 1993-10-06
FI982081A (fi) 1998-09-28
EP0639176A1 (en) 1995-02-22
EP0639176B1 (en) 1996-10-16
IE914146A1 (en) 1992-06-03
DE69122780T2 (de) 1997-02-20
FI118155B (fi) 2007-07-31
JPH06503082A (ja) 1994-04-07
OA09861A (en) 1994-08-15
CZ101993A3 (en) 1994-01-19
CA2099586A1 (en) 1992-05-30
RU2116293C1 (ru) 1998-07-27
CZ282996B6 (cs) 1997-12-17
HU9301568D0 (en) 1993-09-28
JP3375626B2 (ja) 2003-02-10
ZA919401B (en) 1992-07-29
PL167976B1 (pl) 1995-12-30
KR100192196B1 (en) 1999-06-15
EP0571669A1 (en) 1993-12-01
AU644505B2 (en) 1993-12-09
ES2093812T3 (es) 1997-01-01
EP0571669B1 (en) 1996-03-06
DE69122780D1 (de) 1996-11-21
FI982081A0 (fi) 1998-09-28
HUT64219A (en) 1993-12-28
SK281095B6 (sk) 2000-11-07

Similar Documents

Publication Publication Date Title
KR100192196B1 (en) Benzenedimethanol derivatives suitable for micronisation
FI894718A (fi) Pigmentationssupplement foer djurfoderkompositioner.
MY140392A (en) Powder of amino acids and method for producing the same
AU3595893A (en) Elevated temperature dimensionally stable impact modified polyester with low gas permeability
RU93040704A (ru) 1-гидрокси-2-нафталинкарбоксилатная соль 4-гидрокси-альфа-[[[6-(4-фенилбутокси)гексил]амино]метил]-1,3-бензолдиметанола в форме сферических сращений микрокристаллов, способ ее измельчения, способ ее получения, применение гидроксинафтоата для получения измельченной гидроксинафтоатной соли
JPS6413004A (en) Sustained release ferrous sulfate
MY108410A (en) Drug material suitable for micronisation.
EP0829298A3 (de) Verfahren zur Herstellung von Hydroxipivalinsäureneopentylglykolester-Granulaten
EP0393970A3 (en) Cooling of hot bodies
Verkhovskii et al. Structure and Properties of Steels After Quenching in Magnetic Liquid
Nakae The Role of Solidification in Developing Materials
Gooding Zinc" May Lose Market Share"
Yeo et al. The Microstructures and Mechanical Properties of Extruded Bars of Rapidly Solidified Fe--3. 6 C--Si Alloy Powders
Roberts et al. Techniques for Producing Fine Metal Powder
Ermolenko Induced Spin-Orientation Transitions in the Compound TbCo sub 5. 1
Romanovskii et al. BEHAVIOUR OF FeCr 2 O 4 DURING HEATING AND COOLING
Polotnyuk et al. NMR-spectra of exp 59 Co in pre- and post-irradiated Fe sub 84 Co sub 1 B sub 15
Brik et al. Effect of Alloying on the Kinetics of gamma-> alpha Transformation in Alloys on the Cerium Base
Carbonara et al. Rapidly Solidified Powder Processes at Battelle
Zhestkova et al. One-Dimensional Disordering of Epsilon-Prime Martensite in Cobalt--Germanium Alloys
WHITNEY Thomson scattering in a magnetic field(Ph. D. Thesis)
Lu The Applications of the Shape Memory Alloy(SMA) and the Superelastic Alloy
Lapshin A study of grain growth in a solidified casting skin
Murakami et al. Thermodynamic Consideration for Martensitic Transformation of Fe--Mn--Si Shape Memory Alloys
Franek et al. Form of Thermal Curves in Directional Solidification of the Sn--Pb Eutectic Alloy and Pure Tin